drugset / Trial / NCT04495751
Muscadine Grape Extract to Improve Fatigue
Phase 0
Completed
64 enrolled
Wake Forest University Health Sciences
National Cancer Institute (NCI) · collabNational Center for Advancing Translational Sciences (NCATS) · collab
RandomizedParallel-groupDouble-blindSupportive care
Summary
The purpose of this research is to see if muscadine grape extract improves fatigue in people age 70 and above who have a history of treated cancer and report the symptom of fatigue.
Timeline
- Start
- 2021-04-20
- Primary completion
- 2024-08-26
- Completion
- 2024-08-26
Outcome
Missed primary endpoint
registry analysis (superiority test); Muscadine Grape Extract Arm vs Placebo Arm; Mean Difference (Final Values) -1.2 (90% CI -3.5 to 1.1) NCT04495751 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Muscadine grape extract | Unknown | — | Oral |
Indications
No indication recorded.